Ion Beam Applications, SA

Report Publication Announcement • Jan 24, 2013

IBA Announces Full Year Results 2012 Date Change

Results and Conference Call to take place on 18 March 2013

Louvain-la-Neuve, Belgium, January 24, 2013 - IBA (Ion Beam Applications S.A.), the global hightech leader in next generation radiation therapy and diagnostics for the treatment of cancer, announces today that it will issue its business update and financial results for the 2012 financial year on Monday, March 18 2013. The company was originally scheduled to announce results on March 19 2013.

IBA will host a conference call and Q&A session at 2 p.m. CET on Monday, March 18 2013. Olivier Legrain, Chief Executive Officer, and Jean-Marc Bothy, Chief Financial Officer, will host the call which will be conducted in English. The conference call details will be included in the annual results statement to be published on March 18 at 7 a.m. CET.

- Ends -

About IBA

IBA (Ion Beam Applications S.A.), is a cancer diagnostics and treatment company and the worldwide technology leader in the field of proton therapy. The Company's expertise lies in the development of next generation proton therapy technologies and radiopharmaceuticals that provide oncology care providers with premium quality services and equipment, including IBA's leading fully integrated IntegraLab® radiopharmacy system, and Dosimetry advanced solutions for Quality Assurance of medical equipment and increased patient safety.

Headquartered in Belgium and employing more than 1,200 people worldwide, IBA currently has installed systems across Europe and the US and is expanding into emerging markets. The Company is focused on building sustainable global growth for investors, providing solutions in the fight against cancer.

IBA is listed on the pan-European stock exchange EURONEXT. (IBA: Reuters IBAB.BR and Bloomberg IBAB.BB) and more information can be found at: www.iba-worldwide.com

Contact

IBA

Jean-Marc Bothy Chief Financial Officer Tel: +32 10 47 58 90

Thomas Ralet Vice-President Corporate Communication +32 10 47 58 90 communication@iba-group.com

For media and investor enquiries:

M:Communications Mary-Jane Elliott, Amber Bielecka, Claire Dickinson +44 (0) 207 920 2333 IBA@mcomgroup.com

Press release | January 24, 2013 1 | 1